Skip to main content
SpringerLink
Log in

HCV+ donor kidneys for HCV- recipients + DAAs saves cost

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Gupta G, et al. Cost Effectiveness of Hepatitis C Positive Donor Kidney Transplantation for Hepatitis C Negative Recipients with Concomitant Direct-Acting Anti-Viral Therapy. American Journal of Transplantation : 3 Aug 2018. Available from: URL: http://doi.org/10.1111/ajt.15054

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

HCV+ donor kidneys for HCV- recipients + DAAs saves cost. PharmacoEcon Outcomes News 810, 15 (2018). https://doi.org/10.1007/s40274-018-5206-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-5206-6

Search

Navigation